Histopathology and Exercise: A Winning Combination in Pulmonary Fibrosis: A Case Report

References

1. 1.↵
   1. Maher TM

   . A clinical approach to diffuse parenchymal lung disease. Immunol Allergy Clin N Am 2012;32(4):453-472.

   OpenUrlPubMed
2. 2.↵
   1. Martinez FJ

   . Idiopathic interstitial pneumonias: usual interstitial pneumonia versus nonspecific interstitial pneumonia. Proc Am Thorac Soc 2006;3(1):81-95.

   OpenUrlPubMed
3. 3.↵
   1. Travis WD,
   2. King TE,
   3. Bateman ED

   . ATS/ERS international multidisciplinary consensus classification of idiopathic interstitial pneumonias. General principles and recommendations Am J Respir Crit Care Med 2002;165:277-304.

   OpenUrl
4. 4.↵
   1. Ley B,
   2. Collard HR,
   3. King TE Jr.

   . Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2011;183(4):431-440.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.↵
   1. Bjoraker JA,
   2. Ryu JH,
   3. Edwin MK,
   4. Myers JL,
   5. Tazelaar HD,
   6. Schroeder DR,
   7. et al

   . Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998;157(1):199-203.

   OpenUrlCrossRefPubMedWeb of Science
6. 6.↵
   1. Katzenstein AL,
   2. Fiorelli RF

   . Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol 1994;18(2):136-147.

   OpenUrlPubMedWeb of Science
7. 7.↵
   1. Travis WD,
   2. Matsui K,
   3. Moss IE,
   4. Ferrans VJ

   . Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns. Survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. Am J Surg Pathol 2000;24(1):19-38.

   OpenUrlCrossRefPubMedWeb of Science
8. 8.↵
   1. Cottin V,
   2. Donsbeck AV,
   3. Revel D,
   4. Loire R,
   5. Cordier JF

   . Nonspecific interstitial pneumonia. individualization of a clinicopathologic entity in a series of 12 patients. Am J Respir Crit Care Med 1998;158(4):1286-1293.

   OpenUrlPubMedWeb of Science
9. 9.↵
   1. Katzenstein ALA,
   2. Meyers JL

   . Idiopathic pulmonary fibrosis. Clinical relevance of pathologic classification. Am J Crit Care Med 1998;157(4):1301-1315.

   OpenUrlCrossRefPubMedWeb of Science
10. 10.↵
    1. Travis WD,
    2. Hunninghake G,
    3. King TE Jr.,
    4. Lynch DA,
    5. Colby TV,
    6. Brown KK,
    7. et al

    . Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am J Respir Crit Care Med 2008;177(12):1338-1347. Erratum in: Am J Respir Crit Care Med 2008;178(2):211.

    OpenUrlCrossRefPubMedWeb of Science
11. 11.↵
    1. Kim DS,
    2. Collard HR,
    3. King TE Jr.

    . Classification and natural history of the idiopathic interstitial pneumonias. Proc Am Thorac Soc 2006;3(4):285-292.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Riha RL,
    2. Duhig EE,
    3. Clarke BE,
    4. Steele RH,
    5. Slaughter RE,
    6. Zimmerman PV

    . Survival of patients with biopsy-proven usual interstitial pneumonia and nonspecific interstitial pneumonia. Eur Respir J 2002;19(6):1114-1118.

    OpenUrlAbstract/FREE Full Text
13. 13.↵
    1. Park IN,
    2. Jegal Y,
    3. Kim DS,
    4. Do KH,
    5. Yoo B,
    6. Shim TS,
    7. et al

    . Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia. Eur Respir J 2009;33(1):68-76.

    OpenUrlAbstract/FREE Full Text
14. 14.↵
    1. Gleeson M,
    2. Bishop NC,
    3. Stensel DJ,
    4. Lindley MR,
    5. Mastana SS,
    6. Nimmo MA

    . The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease. Nat Rev Immunol 2011;11(9):607-615.

    OpenUrlCrossRefPubMed
15. 15.↵
    1. Gormley J,
    2. Hussey J

    1. O' Neil B,
    2. Bradley J,
    3. Moran F

    . Exercise in the treatment of respiratory disease. In: Gormley J, Hussey J , editors. Exercise therapy: prevention and treatment of disease. Blackwell; 2005:135-168.
16. 16.↵
    1. Garsia-Amerych J,
    2. Lange P,
    3. Benet M,
    4. Schnohr P,
    5. Antó JM

    . Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study. Am J Respir Crit Care Med 2007;175(5):458-463.

    OpenUrlCrossRefPubMedWeb of Science
17. 17.↵
    1. Nici L,
    2. Donner C,
    3. Wouters E,
    4. Zuwallack R,
    5. Ambrosino N,
    6. Bourbeau J,
    7. et al

    ; ATS/ERS Pulmonary Rehabilitation Writing Committee. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 2006;173(12):1390-1413.

    OpenUrlCrossRefPubMedWeb of Science
18. 18.↵
    1. Holland AE,
    2. Hill CJ,
    3. Glaspole I,
    4. Goh N,
    5. McDonald CF

    . Predictors of benefit following pulmonary rehabilitation for interstitial lung disease Respir Med 2012;106(3):429-435.

    OpenUrlCrossRefPubMed
19. 19.↵
    1. Holland AE,
    2. Hill CJ

    . Physical training for interstitial lung disease. Cochrane Database Syst Rev 2008;8(4): CD006322.

    OpenUrl